KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Short-term Investments: 2009-2025

Historic Short-term Investments for Novavax (NVAX) over the last 12 years, with Sep 2025 value amounting to $494.9 million.

  • Novavax's Short-term Investments rose 47.34% to $494.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $494.9 million, marking a year-over-year increase of 47.34%. This contributed to the annual value of $392.9 million for FY2024, which is N/A change from last year.
  • Latest data reveals that Novavax reported Short-term Investments of $494.9 million as of Q3 2025, which was up 38.01% from $358.6 million recorded in Q2 2025.
  • In the past 5 years, Novavax's Short-term Investments registered a high of $494.9 million during Q3 2025, and its lowest value of $2.2 million during Q1 2021.
  • Over the past 2 years, Novavax's median Short-term Investments value was $381.2 million (recorded in 2024), while the average stood at $403.3 million.
  • Its Short-term Investments has fluctuated over the past 5 years, first tumbled by 96.09% in 2021, then surged by 47.34% in 2025.
  • Novavax's Short-term Investments (Quarterly) stood at $2.2 million in 2021, then reached $392.9 million in 2024, then spiked by 47.34% to $494.9 million in 2025.
  • Its Short-term Investments stands at $494.9 million for Q3 2025, versus $358.6 million for Q2 2025 and $468.1 million for Q1 2025.